Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- CBIO
- Price
- -
- Stock movement down
- -0.36 (-1.98%)
- Company name
- Catalyst Biosciences Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 678.29M
- Ent value
- 682.51M
- Price/Sales
- -
- Price/Book
- 192.86
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -431.98%
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -39.21%
- 1 year return
- 5767.28%
- 3 year return
- 82.88%
- 5 year return
- 33.67%
- 10 year return
- -22.79%
Last updated: 2024-12-17
DIVIDENDS
CBIO does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 192.86 |
| EV to Sales | -859.58 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 37.98M |
| EPS (TTM) | -1.17 |
| FCF per share (TTM) | -0.35 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | -794.00K |
| Gross profit (TTM) | -1.59M |
| Operating income (TTM) | -44.26M |
| Net income (TTM) | -44.24M |
| EPS (TTM) | -1.17 |
| EPS (1y forward) | -0.03 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 200.50% |
| Operating margin (TTM) | 5574.56% |
| Profit margin (TTM) | 5572.04% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 2.23M |
| Net receivables | 1.20M |
| Total current assets | 5.13M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 9.96M |
| Accounts payable | 158.00K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 1.78M |
| Total liabilities | 6.45M |
| Shareholder's equity | 3.52M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -13.38M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -13.38M |
| Dividends paid (TTM) | 57.80M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -1257.95% |
| Return on Assets | -444.02% |
| Return on Invested Capital | -1257.95% |
| Cash Return on Invested Capital | -380.41% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| CBIO | S&P500 | |
| Current price drop from All-time high | -98.86% | - |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 13 May 2022 | 9 Mar 2009 |
| Avg drop from high | -73.24% | -11.07% |
| Avg time to new high | 79 days | 12 days |
| Max time to new high | 3253 days | 1805 days |
COMPANY DETAILS
Marketcap
678.29M
Marketcap category
Small-cap
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of liver fibrosis associated with a broad spectrum of chronic liver diseases in the United States and internationally. It develops Hydronidone, that has completed phase 1 clinical trial for the treatment of nonalcoholic steatohepatitis, a severe form of nonalcoholic fatty liver disease. The company was founded in 2002 and is headquartered in South San Francisco, California.
Employees
7
Investor relations
-
SEC filings
CEO
Nassim Usman
Country
USA
City
South San Francisco
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner